Visual compatibility of foscarnet with other injectable drugs during simulated Y-site administration.
Baltz
J K
JK
National Cancer Institute-Navy Medical Oncology Branch, National Naval Medical Center, Bethesda, MD 20814.
Kennedy
P
P
Minor
J R
JR
Gallelli
J
J
D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy; D000998:Antiviral Agents / Q000008:administration & dosage*; D002855:Chromatography, Thin Layer; D004338:Drug Combinations; D004344:Drug Incompatibility; D017245:Foscarnet; D006801:Humans; D006863:Hydrogen-Ion Concentration; D007262:Infusions, Intravenous; D010746:Phosphonoacetic Acid / Q000008:administration & dosage / Q000031:analogs & derivatives*
D000998:Antiviral Agents; D004338:Drug Combinations; D017245:Foscarnet; D010746:Phosphonoacetic Acid